@pedro I am sceptical yes. Especially with the spelling mistake, also not sure they would put sample size next to sensitivity and specificity as the average punter won't care. BUT as I say no disputing they have registered that trademark and were at medica.
Either way HUA is coming and desktop review so all good.
One other point though and bearing in mind this is the government if desktop review is taking place on a file with Affidx all over it. What do they do when meduflow appears ( hopefully common sense built in for a rebrand)
So if Amazon launched a product called Amaflow advertised with affimers inside, it wouldn't be news?
I think it is news because the only RNS we have regarding medusa is an exclusive distribution agreement of our test direct to consumer globally.
What we know has been validated and indeed already sold to businesses is AffiDX.
What we see in meduflow is a new product (ok it's Affidx rebranded). Which to me should have been followed by the massive powerhouse of e-commerce and social media skills that Medusa possess.
BUT we don't have HUA yet so maybe that is why it's exceptionally low key and when that lands they will also announce the home use version is MeduFlow.
I have to say I find it hard to believe that medusa were at medica and there is only 1 random twitter user who has an image of the brochure for their new product.
Medusa/Boohoo masters of social media and advertising, not sure this would be the case.
L2 ON FIRE, mm's playing games, hold on to your golden tickets, they'll buy all mine and more well over ask, can't buy a bean, shorts burning, wouldn't want to be out!!!!
Avacta would have known Medusa were at MEDICA pushing this device so you would have thought if true and the nomad deems it RNS worthy they would have had to have announced it before the trade show.
still a bit sceptical, but no disputing the trademark registration